Leal Therapeutics, Inc., a biotechnology company developing novel therapeutics for patients with disorders of the central nervous system (CNS), announced a $45 million financing. The...
Traumasoft, a leading provider of integrated cloud-based software for emergency medical services (EMS) organizations, is pleased to announce the appointment of Dave O'Reilly as...
Pulse Biosciences, Inc., a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation technology, announced the appointment of David Kenigsberg, M.D. as Chief...
Biogen Inc. has appointed Daniel Quirk, M.D., M.P.H., M.B.A. as Chief Medical Officer and Head of Medical Affairs, effective October 28, 2024. Dr. Quirk...
Biogen Inc, and Neomorph Inc. announced a research collaboration to discover and develop molecular glue degraders for priority targets in Alzheimer’s, rare neurological, and...
